Episode 1, Part 3 of PharmTech AI Pulse Check covers why INTerpath-001's AI isn't ChatGPT and names pharma manufacturing's biggest AI governance gaps.
News|Articles|February 4, 2019
- Pharmaceutical Technology\'s In the Lab eNewsletter-02-06-2019
- Volume 14
- Issue 2
New Reactor Flask Heating System Offers Safe Lab Option
Author(s)Pharmaceutical Technology Editors
A new reactor flask heating system now offered by Asynt allows the conduction of safe experiments in academic teaching and research labs.
Advertisement
The new DrySyn UNO Base, a versatile entry-level reactor flask heating system with heat resistant handle introduced by Asynt, a supplier of laboratory products and services, offers a way to conduct safe experiments in academic teaching and research labs.
The new DrySyn UNO Base, a versatile entry-level reactor flask heating system with heat resistant handle introduced by Asynt, a supplier of laboratory products and services, offers a way to conduct safe experiments in academic teaching and research labs.
Designed and manufactured in the United Kingdom, the DrySyn UNO Base provides a simple but effective tool for safe heating and clamping of a single flask or vial using a DrySyn Reaction Vial insert. The base itself has a flat bottom with removable/repositionable feet that make it suitable for use on any standard magnetic hotplate stirrer.
The base is constructed of robust solid anodized aluminum which enhances the heating system’s performance without the need for messy and potentially hazardous oil baths, according to the company.
Source:
Articles in this issue
over 7 years ago
Ensuring mAb Stability Through Modelingover 7 years ago
Exploring Solubility Solutionsover 7 years ago
Liquid Handlers for Automated Lab Workflowsover 7 years ago
Horizon Discovery, Rutgers Join Forces for Gene Editingover 7 years ago
Waters Launches SmartMS-Enabled LC–MS Biopharma Systemover 7 years ago
Taconic Sends Mice into Space for Therapeutic Researchover 7 years ago
Allergan to Establish R&D Presence in Cambridge, MAover 7 years ago
MedPharm Expands US Center of ExcellenceAdvertisement
Related to this article
Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.
FDA approves tavapadon, first D1/D5 agonist, validating AbbVie's $8.7B Cerevel deal and an October five-strength oral tablet launch.
Richard Jaenisch weighs how FDA's new NAM rule could reshape preclinical testing and what CMC teams should do now, on Manufacturing Intelligence.
In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor, PhD, AbbVie, and Swita Singh, PhD, Bristol Myers Squibb, discuss the implementation of risk-based approaches for CMC.
Merck licenses SciBrunch's preclinical KRAS G12D inhibitor for $2.13B, raising tech transfer and scale-up questions for oral cancer drug development.
Ronald Piervincenzi, USP, urges drugmakers and purchasers to act on supply chain resilience to curb drug shortages and shape better policy.
Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
Advertisement
Advertisement